Literature DB >> 8297334

In vitro splicing of pre-messenger RNA with extracts from 5-fluorouridine-treated cells.

J R Patton1.   

Abstract

The effect of 5-fluorouridine (5-FU) treatment of cells on the splicing of pre-mRNA was determined using cellular extracts and splicing in vitro. Nuclear extracts from control cells and cells treated with 5-FU were prepared and used to splice pre-mRNAs in vitro. The drug treatment resulted in inhibition of cell growth but had little effect on RNA synthesis. The extracts from 5-FU-treated cells showed significant inhibition of splicing. This inhibition was the result of reduced efficiency and was not caused by a block at a specific step in the splicing pathway. There were no observable changes in the levels or physical properties of the small nuclear ribonucleoprotein particles that are essential cofactors in the splicing process. The deficiency in splicing in the extracts from 5-FU-treated cells could be supplemented by the addition of complementary fractions from a control extract.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8297334      PMCID: PMC1137828          DOI: 10.1042/bj2970297

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

1.  U5 small nuclear ribonucleoprotein: RNA structure analysis and ATP-dependent interaction with U4/U6.

Authors:  D L Black; A L Pinto
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

2.  U2 small nuclear RNP assembly in vitro.

Authors:  A M Kleinschmidt; J R Patton; T Pederson
Journal:  Nucleic Acids Res       Date:  1989-06-26       Impact factor: 16.971

3.  Excision of an intact intron as a novel lariat structure during pre-mRNA splicing in vitro.

Authors:  B Ruskin; A R Krainer; T Maniatis; M R Green
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

4.  Gel electrophoretic isolation of splicing complexes containing U1 small nuclear ribonucleoprotein particles.

Authors:  M Zillmann; M L Zapp; S M Berget
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

5.  A factor, U2AF, is required for U2 snRNP binding and splicing complex assembly.

Authors:  B Ruskin; P D Zamore; M R Green
Journal:  Cell       Date:  1988-01-29       Impact factor: 41.582

6.  Inhibition of pre-mRNA splicing by 5-fluoro-, 5-chloro-, and 5-bromouridine.

Authors:  H Sierakowska; R R Shukla; Z Dominski; R Kole
Journal:  J Biol Chem       Date:  1989-11-15       Impact factor: 5.157

7.  5-Fluorouracil inhibits dihydrofolate reductase precursor mRNA processing and/or nuclear mRNA stability in methotrexate-resistant KB cells.

Authors:  C L Will; B J Dolnick
Journal:  J Biol Chem       Date:  1989-12-15       Impact factor: 5.157

Review 8.  Metabolism and mechanism of action of 5-fluorouracil.

Authors:  W B Parker; Y C Cheng
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

9.  Nucleoside transport in L1210 murine leukemia cells. Evidence for three transporters.

Authors:  C R Crawford; C Y Ng; L D Noel; J A Belt
Journal:  J Biol Chem       Date:  1990-06-15       Impact factor: 5.157

Review 10.  Enhancement of 5-fluorouracil's anticancer activity by dipyridamole.

Authors:  J L Grem; P H Fischer
Journal:  Pharmacol Ther       Date:  1989       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.